0 0 Gray's Inn Medical Group Ltd 13917404 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is Management consultancy activities other than financial management Digita Accounts Production Advanced 6.30.9574.0 true 13917404 2024-03-01 2025-02-28 13917404 2025-02-28 13917404 bus:OrdinaryShareClass1 2025-02-28 13917404 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 13917404 core:OtherPropertyPlantEquipment 2025-02-28 13917404 bus:SmallEntities 2024-03-01 2025-02-28 13917404 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13917404 bus:FilletedAccounts 2024-03-01 2025-02-28 13917404 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13917404 bus:RegisteredOffice 2024-03-01 2025-02-28 13917404 bus:CompanySecretaryDirector1 2024-03-01 2025-02-28 13917404 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 13917404 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13917404 bus:Agent1 2024-03-01 2025-02-28 13917404 core:OtherPropertyPlantEquipment 2024-03-01 2025-02-28 13917404 core:PlantMachinery 2024-03-01 2025-02-28 13917404 countries:England 2024-03-01 2025-02-28 13917404 2024-02-29 13917404 core:OtherPropertyPlantEquipment 2024-02-29 13917404 2023-03-01 2024-02-29 13917404 2024-02-29 13917404 bus:OrdinaryShareClass1 2024-02-29 13917404 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 13917404 core:OtherPropertyPlantEquipment 2024-02-29 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 13917404

Gray's Inn Medical Group Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 28 February 2025

 

Gray's Inn Medical Group Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Gray's Inn Medical Group Ltd

Company Information

Director

Dr Pezhman Fard

Company secretary

Dr Pezhman Fard

Registered office

Charles Rippin & Turner 130 College Road, Middlesex House, Harrow, England, HA1 1BQ

Accountants

Charles Rippin and Turner Limited Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

Gray's Inn Medical Group Ltd

(Registration number: 13917404)
Abridged Balance Sheet as at 28 February 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

1,300,354

658,801

Current assets

 

Cash at bank and in hand

 

204,184

134,843

Creditors: Amounts falling due within one year

(91,186)

(136,927)

Net current assets/(liabilities)

 

112,998

(2,084)

Total assets less current liabilities

 

1,413,352

656,717

Accruals and deferred income

 

(32,500)

-

Net assets

 

1,380,852

656,717

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

1,380,851

656,716

Shareholders' funds

 

1,380,852

656,717

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 20 March 2025
 

.........................................
Dr Pezhman Fard
Company secretary and director

 

Gray's Inn Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Charles Rippin & Turner 130 College Road, Middlesex House, Harrow, England, HA1 1BQ

These financial statements were authorised for issue by the director on 20 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Gray's Inn Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

12% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

 

Gray's Inn Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2025

4

Tangible assets

Other tangible assets
£

Total
£

Cost or valuation

At 1 March 2024

731,904

731,904

Additions

703,691

703,691

At 28 February 2025

1,435,595

1,435,595

Depreciation

At 1 March 2024

73,103

73,103

Charge for the year

62,138

62,138

At 28 February 2025

135,241

135,241

Carrying amount

At 28 February 2025

1,300,354

1,300,354

At 29 February 2024

658,801

658,801

5

Debtors

Debtors includes £Nil (2024 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1